Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Gilson

Showing results (191-200 of 202) with videos related to

Pageof 21
Sort By:
Molecular Microbiology|April 11, 2022
The Plasmodium falciparum parasitophorous vacuole protein P113 interacts with the parasite protein export machinery and maintains normal vacuole architectureHayley E Bullen, Paul R Sanders, Madeline G Dans, et al.
Antimicrobial Agents and Chemotherapy|December 19, 2018
Evaluation of 4-Amino 2-Anilinoquinazolines against <i>Plasmodium</i> and Other Apicomplexan Parasites <i>In Vitro</i> and in a <i>P. falciparum</i> Humanized NOD-<i>scid</i> IL2Rγ<sup>null</sup> Mouse Model of MalariaPaul R Gilson, William Nguyen, William A Poole, et al.
Scientific Reports|July 18, 2019
A 4-cyano-3-methylisoquinoline inhibitor of Plasmodium falciparum growth targets the sodium efflux pump PfATP4Paul R Gilson, Rasika Kumarasingha, Jennifer Thompson, et al.
European Journal of Medicinal Chemistry|March 30, 2024
Activity refinement of aryl amino acetamides that target the P. falciparum STAR-related lipid transfer 1 proteinWilliam Nguyen, Coralie Boulet, Madeline G Dans, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 19, 2013
Identification and prioritization of merozoite antigens as targets of protective human immunity to Plasmodium falciparum malaria for vaccine and biomarker developmentJack S Richards, Thangavelu U Arumugam, Linda Reiling, et al.
Journal of Medicinal Chemistry|July 18, 2025
Optimization and Characterization of the Antimalarial Activity of <i>N</i>-Aryl Acetamides that are Susceptible to Mutations in ROM8 and CSC1William Nguyen, Coralie Boulet, Madeline G Dans, et al.
Plos Biology|April 13, 2023
Sulfonylpiperazine compounds prevent Plasmodium falciparum invasion of red blood cells through interference with actin-1/profilin dynamicsMadeline G Dans, Henni Piirainen, William Nguyen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 2017
Development of a Novel CD4<sup>+</sup> TCR Transgenic Line That Reveals a Dominant Role for CD8<sup>+</sup> Dendritic Cells and CD40 Signaling in the Generation of Helper and CTL Responses to Blood-Stage MalariaDaniel Fernandez-Ruiz, Lei Shong Lau, Nazanin Ghazanfari, et al.
Nature Communications|June 18, 2024
Aryl amino acetamides prevent Plasmodium falciparum ring development via targeting the lipid-transfer protein PfSTART1Madeline G Dans, Coralie Boulet, Gabrielle M Watson, et al.
Nature Communications|September 30, 2024
Author Correction: Aryl amino acetamides prevent Plasmodium falciparum ring development via targeting the lipid-transfer protein PfSTART1Madeline G Dans, Coralie Boulet, Gabrielle M Watson, et al.
Pageof 21

Showing results (191-200 of 202) with videos related to

Sort By:
Pageof 21
Molecular Microbiology|April 11, 2022
The Plasmodium falciparum parasitophorous vacuole protein P113 interacts with the parasite protein export machinery and maintains normal vacuole architectureHayley E Bullen, Paul R Sanders, Madeline G Dans, et al.
Antimicrobial Agents and Chemotherapy|December 19, 2018
Evaluation of 4-Amino 2-Anilinoquinazolines against <i>Plasmodium</i> and Other Apicomplexan Parasites <i>In Vitro</i> and in a <i>P. falciparum</i> Humanized NOD-<i>scid</i> IL2Rγ<sup>null</sup> Mouse Model of MalariaPaul R Gilson, William Nguyen, William A Poole, et al.
Scientific Reports|July 18, 2019
A 4-cyano-3-methylisoquinoline inhibitor of Plasmodium falciparum growth targets the sodium efflux pump PfATP4Paul R Gilson, Rasika Kumarasingha, Jennifer Thompson, et al.
European Journal of Medicinal Chemistry|March 30, 2024
Activity refinement of aryl amino acetamides that target the P. falciparum STAR-related lipid transfer 1 proteinWilliam Nguyen, Coralie Boulet, Madeline G Dans, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 19, 2013
Identification and prioritization of merozoite antigens as targets of protective human immunity to Plasmodium falciparum malaria for vaccine and biomarker developmentJack S Richards, Thangavelu U Arumugam, Linda Reiling, et al.
Journal of Medicinal Chemistry|July 18, 2025
Optimization and Characterization of the Antimalarial Activity of <i>N</i>-Aryl Acetamides that are Susceptible to Mutations in ROM8 and CSC1William Nguyen, Coralie Boulet, Madeline G Dans, et al.
Plos Biology|April 13, 2023
Sulfonylpiperazine compounds prevent Plasmodium falciparum invasion of red blood cells through interference with actin-1/profilin dynamicsMadeline G Dans, Henni Piirainen, William Nguyen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 2017
Development of a Novel CD4<sup>+</sup> TCR Transgenic Line That Reveals a Dominant Role for CD8<sup>+</sup> Dendritic Cells and CD40 Signaling in the Generation of Helper and CTL Responses to Blood-Stage MalariaDaniel Fernandez-Ruiz, Lei Shong Lau, Nazanin Ghazanfari, et al.
Nature Communications|June 18, 2024
Aryl amino acetamides prevent Plasmodium falciparum ring development via targeting the lipid-transfer protein PfSTART1Madeline G Dans, Coralie Boulet, Gabrielle M Watson, et al.
Nature Communications|September 30, 2024
Author Correction: Aryl amino acetamides prevent Plasmodium falciparum ring development via targeting the lipid-transfer protein PfSTART1Madeline G Dans, Coralie Boulet, Gabrielle M Watson, et al.
Pageof 21